Handelsavisen
prelaunch
Companies Healthcare ADUS.O
AD
ADUS.O NASDAQ Health Care Providers & Services

Addus Homecare Corp

$110,10
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
Op margin
9,7 %
ROE
8,8 %
Net margin
6,7 %
Debt / equity
0,11
Beta
52w range
Volume
Day range
Prev close
$111,92
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Addus Homecare Corp provides home health care services, generating revenue primarily through government-funded programs, with the Illinois Department on Aging representing a significant portion of its net service revenues.

Business. Addus Homecare Corp (ADUS.O) is a health care provider and services company listed on the NASDAQ exchange. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments and geographic presence are not provided in the available data. The company is headquartered in the United States.

Classification85 %
SectorHealth Care
Industry groupHealth Care Providers & Services
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
EATON VANCE MANAGEMENT
largest disclosed fund holder
Profitability
8,8 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ADUS.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Consumer Discretionary+0,4 %+7,7 %−0,2 %
    Information Technology+0,3 %+7,8 %−0,3 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ADUS.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Addus Homecare Corp (ADUS.O) is a health care provider and services company listed on the NASDAQ exchange. The firm operates within the Health Care Providers & Services industry, generating revenue through service-based models. Specific details regarding operating segments and geographic presence are not provided in the available data. The company is headquartered in the United States.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Providers & Services
    AI synthesis
    GENERATED

    Addus Homecare Corp maintains a conservative capital structure characterized by low leverage and strong equity backing. The company reports total assets of $1.44 billion against total liabilities of $352 million, resulting in a debt-to-equity ratio of 0.11. Long-term debt stands at $121 million, which is modest relative to the $1.09 billion in total equity. Despite the low leverage, the risk assessment flags medium liquidity risk and notes that net cash is negative after subtracting total debt, suggesting that while the balance sheet is not over-leveraged, the company carries debt obligations that exceed its immediate cash holdings. Operating cash flow of $111.5 million supports these obligations, with capital expenditures remaining low at $7.7 million, indicating a capital-light operational model.

    Profitability metrics indicate efficient asset utilization and moderate returns on equity. The company generated net income of $95.9 million on revenue of $1.42 billion, yielding a net margin of approximately 6.7%. Return on equity (ROE) is 8.84%, and return on assets (ROA) is 6.67%, reflecting the company's ability to generate profits from its asset base. Gross profit of $461.9 million suggests a gross margin of roughly 32.5%, which is typical for service-oriented health care providers where labor costs are significant. Operating income of $138.6 million demonstrates effective cost control relative to revenue generation.

    Revenue concentration is a notable feature of the company's business model, particularly regarding its reliance on specific government payers. The Illinois Department on Aging accounted for 18.1% of net service revenues in 2025 and 21.0% in 2024, highlighting a significant dependency on a single state-level customer. This concentration exposes the company to regulatory and reimbursement rate changes specific to Illinois, although the diversification across other payers mitigates total revenue risk. The absence of detailed segment or geographic breakdowns beyond this key customer relationship limits a more granular analysis of revenue mix, but the disclosed dependency underscores the importance of maintaining strong relationships with state health agencies.

    Growth trajectory analysis is constrained by the absence of historical period data in the provided input. Without multi-year revenue or net income trends, it is not possible to assess the company's historical growth rate or momentum. However, the current revenue base of $1.42 billion suggests a mature operation with substantial scale in the home health care market. The stability of the key customer relationship, with the Illinois Department on Aging maintaining a consistent share of revenue between 2024 and 2025, implies steady demand from this segment.

    Risk factors include medium liquidity risk and low dilution risk. The negative net cash position after debt subtraction is a key flag, indicating that the company must manage its debt service obligations carefully despite its strong operating cash flow. Dilution risk is assessed as low, with basic and diluted shares outstanding being identical at 18.6 million, suggesting no significant options or convertible securities are currently impacting share count. The primary operational risk stems from the concentration of revenue from the Illinois Department on Aging, which could be affected by changes in state funding or reimbursement policies.

    Recent events include internal reconciler activities related to coverage closure and analysis job processing, which are operational metadata rather than business developments. There are no significant news events, filing observations, or transcript observations provided that indicate recent strategic shifts, mergers, or regulatory actions. The lack of recent public disclosures suggests a period of operational stability without major corporate actions.

    Key takeaways
    • Low leverage with a debt-to-equity ratio of 0.11 and strong equity base of $1.09 billion.
    • Significant revenue concentration with the Illinois Department on Aging accounting for 18.1% of 2025 revenues.
    • Moderate profitability with 8.84% ROE and 6.67% ROA.
    • Medium liquidity risk due to negative net cash position after debt subtraction.
    • Low dilution risk with no difference between basic and diluted shares outstanding.
    • Capital-light model with low capital expenditures relative to operating cash flow.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $110,10
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.09B
    Net cash
    -$121.0M
    Current ratio
    Debt / equity
    0.1
    ROA
    6.7%
    ROE
    8.8%
    Cash conversion
    116.0%
    CapEx / revenue
    0.5%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Customers1
    ANON:CUST:ADUS.O:IllinoisDepartmentonAginANON:CUST:ADUS.O:IllinoisDepartmentonAginCustomer88%Source ↗

    Supply chain

    Vendors → ADUS ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSADUSADUSAddus Homecare Corp1 entityANON:CUST:ADUS.O:Illin
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-07-04

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution14 analysts
    Strong buy5
    Buy7
    Hold1
    Sell1
    Strong sell0
    12-month price target$133,00 · Median $135,00
    Low $96,00High $155,00
    Operating income · consensus176,0M USD
    EPS surprise
    −10,9 %
    reported vs consensus · miss
    Revenue surprise
    −6,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$96,00
    Mean$133,00
    Median$135,00
    High$155,00
    Spot$110,10
    +20.8 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin9,7 %Above P75
    Net Margin6,7 %Above P75
    ROE8,8 %Above median
    Capex / Rev0,5 %Above median
    D/E0,11Above median
    Cash Conv1,16Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Return On Equity
      net_income / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Return On Assets
      net_income / total_assets
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    Source documents
    • Addus HomeCare Corp Market data — financials · 2026-07-26
    • reconciler_enqueue (reconciler) on ADUS.O · 2026-07-26
    • Addus Homecare Corp HA canonical relationships · 2026-07-26

    Ownership & reference

    Top holders

    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,11 %$0M
    • Capital Research Global InvestorsInvestment Managers · as of 2026-03-310,02 %$144M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,02 %$41M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,02 %$30M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,01 %$70M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$333M
    • Wellington Management Company, LLPInvestment Managers · as of 2026-03-310,01 %$36M
    • Invesco QQQ TrustFunds · as of 2026-03-310,01 %$39M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,01 %$19M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,00 %$11M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$22M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$22M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$45M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$42M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$68M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$141M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$3M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$10M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$5M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$33M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$7M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$9M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$6M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$3M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$2M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$1M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • R. Dirk AllisonChairman of the Board, Chief Executive Officer

    Insider activity

    Net selling0 buys · 27 sellsnet -$2,1M17 insiders · last 365d
    • Dixon Heather BriannePresident and Chief Operating · Common StockSold 288 @ $93,77$27K · 2026-06-22
    • Weaver Susan TDirector · Common StockOther 1 449 · 2026-06-10
    • Lopez EstebanDirector · Common StockOther 1 449 · 2026-06-10
    • Hill-Milbourne VeronicaDirector · Common StockOther 1 449 · 2026-06-10
    • Gordon Darin J.Director · Common StockOther 1 449 · 2026-06-10
    • FIRST MARK LDirector · Common StockOther 1 449 · 2026-06-10
    • EARLEY MICHAELDirector · Common StockOther 1 449 · 2026-06-10
    • RUSH JEANDirector · Common StockOther 1 449 · 2026-06-10
    • Lopez EstebanDirector · Common StockSold 250 @ $93,00$23K · 2026-05-21
    • Lopez EstebanDirector · Common StockSold 250 @ $93,00$23K · 2026-05-19
    • BLESSING CLIFF DONALDEVP, Chief Development Officer · Common StockSold 178 @ $93,61$17K · 2026-04-21
    • RAINES MONICAEVP, CCO and Quality Officer · Common StockSold 224 @ $102,15$23K · 2026-03-02
    • Stevenson Roberton JamesEVP, Chief HR Officer · Common StockSold 284 @ $105,36$30K · 2026-02-25
    • GAFFNEY SEANEVP, Chief Legal Officer · Common StockSold 442 @ $105,36$47K · 2026-02-25
    • POFF BRIANEVP, Chief Financial Officer · Common StockSold 820 @ $105,36$86K · 2026-02-25
    • ALLISON R DIRKDirector, Chairman and CEO · Common StockSold 2 364 @ $105,36$249K · 2026-02-25
    • BLESSING CLIFF DONALDEVP, Chief Development Officer · Common StockSold 177 @ $105,36$19K · 2026-02-25
    • RAINES MONICAEVP, CCO and Quality Officer · Common StockSold 219 @ $105,36$23K · 2026-02-25
    • WATTENBARGER MICHAEL D.EVP, Chief Information Officer · Common StockSold 300 @ $105,36$32K · 2026-02-25
    • TUCKER DAVID W.EVP, Chief Strategy Officer · Common StockSold 379 @ $105,36$40K · 2026-02-25
    • Anderson DarbyEVP, Chief Govt Rel Officer · Common StockSold 396 @ $105,36$42K · 2026-02-25
    • ALLISON R DIRKDirector, Chairman and CEO · Common StockSold 4 988 @ $106,98$534K · 2026-02-24
    • RAINES MONICAEVP, CCO and Quality Officer · Common StockSold 437 @ $106,99$47K · 2026-02-24
    • Stevenson Roberton JamesEVP, Chief HR Officer · Common StockSold 567 @ $107,35$61K · 2026-02-24
    • BLESSING CLIFF DONALDEVP, Chief Development Officer · Common StockSold 350 @ $107,14$37K · 2026-02-24

    Short positioning

    1.3Mshares short+18.6% vs prior
    4.99days to cover
    63.1%short of daily vol
    708fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ADUS.OCanonical
    NASDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    ADUSANON:CUSHealth Care Pr
    This companySectorCustomers

    Evidence & claims

    From filings & derived data
    • EPS (basic) (annual): USD-PER-SHARES 5Unknown
    • EPS (diluted) (annual): USD-PER-SHARES 5Unknown
    • Total operating expenses (annual): USD 323.26MUnknown
    • Cost of revenue (annual): USD 960.66MUnknown
    • Pre-tax income (annual): USD 127.44MUnknown
    • Gross profit (annual): USD 461.87MUnknown
    • Shares outstanding (annual): 18.52MUnknown
    • Shareholders' equity (annual): USD 1.09BUnknown
    • Long-term debt (annual): USD 120.96MUnknown
    • Current liabilities (annual): USD 149.49MUnknown
    • Total liabilities (annual): USD 352MUnknown
    • Operating cash flow (annual): USD 111.51MUnknown
    • Total assets (annual): USD 1.44BUnknown
    • Capex (annual): USD 7.72MUnknown
    • Current assets (annual): USD 269.49MUnknown
    • Revenue (annual): USD 1.42BUnknown
    • Operating income (annual): USD 138.62MUnknown
    • Net income (annual): USD 95.91MUnknown
    • Operating cash flow (annual): USD 116.43MUnknown
    • EPS (basic) (annual): USD-PER-SHARES 4Unknown
    • Shareholders' equity (annual): USD 970.49MUnknown
    • Cash & equivalents (annual): USD 98.91MUnknown
    • Total liabilities (annual): USD 442.14MUnknown
    • Shares outstanding (annual): 18.15MUnknown
    Showing 24 of 37 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-04 04:28 UTCFILINGMaterial 8-K
    2026-08-04EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-08-03 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-08-03EVENTQ2 2026 earnings (expected) estimated date
    2026-06-22 00:00 UTCINSIDER8 insider transactions — 2026-06
    2026-06-22 00:00 UTCINSIDER8 insider transactions — 2026-06
    2026-06-22INSIDERDixon Heather Brianne sold 288 sh — President and Chief Operating ~$27k
    2026-06-10FILINGFORM 8-K →
    2026-06-10INSIDERWeaver Susan T transacted 1.4k sh — Director
    2026-06-10INSIDERLopez Esteban transacted 1.4k sh — Director
    2026-06-10INSIDERHill-Milbourne Veronica transacted 1.4k sh — Director
    2026-06-10INSIDERGordon Darin J. transacted 1.4k sh — Director
    2026-06-10INSIDERFIRST MARK L transacted 1.4k sh — Director
    2026-06-10INSIDEREARLEY MICHAEL transacted 1.4k sh — Director
    2026-06-10INSIDERRUSH JEAN transacted 1.4k sh — Director
    2026-05-21 00:00 UTCINSIDER2 insider transactions — 2026-05
    2026-05-21 00:00 UTCINSIDER2 insider transactions — 2026-05
    2026-05-21INSIDERLopez Esteban sold 250 sh — Director ~$23k
    2026-05-19INSIDERLopez Esteban sold 250 sh — Director ~$23k
    2026-05-05FILINGFORM 10-Q →
    2026-05-04FILINGFORM 8-K →
    2026-04-23FILINGFORM DEF 14A →
    2026-04-21 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-21 00:00 UTCINSIDER1 insider transaction — 2026-04
    2026-04-21INSIDERBLESSING CLIFF DONALD sold 178 sh — EVP, Chief Development Officer ~$17k
    2026-03-02 00:00 UTCINSIDER1 insider transaction — 2026-03
    2026-03-02 00:00 UTCINSIDER1 insider transaction — 2026-03
    2026-03-02INSIDERRAINES MONICA sold 224 sh — EVP, CCO and Quality Officer ~$23k
    2026-02-25INSIDERStevenson Roberton James sold 284 sh — EVP, Chief HR Officer ~$30k
    2026-02-25INSIDERGAFFNEY SEAN sold 442 sh — EVP, Chief Legal Officer ~$47k
    2026-02-25INSIDERPOFF BRIAN sold 820 sh — EVP, Chief Financial Officer ~$86k
    2026-02-25INSIDERALLISON R DIRK sold 2.4k sh — Director, Chairman and CEO ~$249k
    2026-02-25INSIDERBLESSING CLIFF DONALD sold 177 sh — EVP, Chief Development Officer ~$19k
    2026-02-25INSIDERRAINES MONICA sold 219 sh — EVP, CCO and Quality Officer ~$23k
    2026-02-25INSIDERWATTENBARGER MICHAEL D. sold 300 sh — EVP, Chief Information Officer ~$32k
    2026-02-25INSIDERTUCKER DAVID W. sold 379 sh — EVP, Chief Strategy Officer ~$40k
    2026-02-25INSIDERAnderson Darby sold 396 sh — EVP, Chief Govt Rel Officer ~$42k
    2026-02-24FILINGFORM 10-K →
    2026-02-24INSIDERALLISON R DIRK sold 5.0k sh — Director, Chairman and CEO ~$534k
    Showing the 40 most recent of 50 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage